SlideShare a Scribd company logo
1 of 51
Download to read offline
Avenova
(formerly i-Lid™
Cleanser)
A NEW DIMENSION IN LID AND LASH HYGIENE
Ron Najafi, Ph.D.
Chairman & CEO
NovaBay Pharmaceuticals, Inc.
email: Rnajafi@NovaBay.com
(New York Stock Exchange: NBY)
The San Francisco Bay Area
Home to NovaBay Pharmaceuticals
(A view from our facilities)
NovaBay Pharmaceuticals
Employees: 28, founded in 2000 by Ron Najafi, Ph.D. (chemist)
NovaBay Dedicated Sales Force: 39, all across the US
Location: Emeryville, CA
Capital Structure: Public Company, listed on NYSE: NBY
Focus: Non-Antibiotic Antimicrobials
Marketed products (Neutrox platform)
– Avenova: (formerly i-Lid™ Cleanser ) . Lid & Lash Hygiene, Blepharitis,
MGD and Dry Eye.
– NeutroPhase: Diabetic Ulcer, Venous and Pressure Ulcers, including NF)
– CelleRx: Burn associated with Post Laser Resurfacing
Pre-Market Products (Aganocide platform)
– Bladder Irrigation Solution for patients with Spinal Cord Injury and recurrent
blockage and encrustation
– Skin Infection (Impetigo and Acne)
Global Partnerships: PBE (in the US), IHT (USA), Galderma (France), Virbac
(France), Pioneer Pharma (China and Southeast Asia), Shin Poong (Korea), Biopharm
(North African and Middle East)
“The Most Under-
recognized
The Most
Underappreciated
The Most Undertreated
disease
in Ophthalmic Care”
Anatomy of Eye and Lid and
Meibomian Gland
Blepharitis: Infection and
Inflammation of EyeLid
Blepharitis Causes:
Meibomian Gland Dysfunction (MGD).
Gland Oil Keep
the water from
evaporating &
preventing Dry
Eye.
Expressing the Meibomian Gland
Shows Dysfunction present
Tooth Paste
like
consistency is
bad
Doctor is
pressing
against lower
eye lid
Blepharitis / Meibomian Gland Dysfunction/
Associated Dry Eye / Pre-Operative Lid
Hygiene
Chronic lid & lash hygiene
 - 24 million blepharitis patients
 - 6.5 million MGD dry eye patients
 - 3 million cataract patients
 - 1.5 million refractive surgery patients
Avenova (formerly i-Lid™
Cleanser)
for Conditions of the Lids and Lashes
Proprietary Technology
– Neutrox : NovaBay Proprietary Pure 0.01% Pure hypochlorous
solution in saline
– No bleach impurities, which is present in Dakin and Dakin-like
solutions
– No resistance expected based on novel mechanism of action
Significant Market / Poorly Served
– Eyelid hygiene therapy, part of the treatment for blepharitis
– Currently marketed products have little to no benefit
– 4% of 18 – 22 year olds
– 71% of 65+ year olds
Why Control of Lid Flora Matters?
Blepharitis
MGD with secondary staph
overpopulation
Pre-op surgical prophylaxis
– Refractive
– Cataract
– Retinal
Contact lens wear
Does not
generate
Resistance
Mechanical
Debridement
Anti-Toxin
Anti-biofilm
Activity
Bacterial
Removal✓
✓
✓
✓
✓
Blepharitis
MGD
Multifactorial
Chronic
Disease
Affects
Quality of life
Does not
generate
Resistance
Mechanical
Debridement
Anti-Toxin
Anti-biofilm
Activity
Bacterial
Removal✓
✓
✓
✓
✓
Omega 3
Fatty Acid
Omega 3 Fatty Acid,
Rich in EPA & DHA
Eicosapentaenoic Acid (EPA), 20 carbons and 5 double bonds.
Docosahexaenoic Acid (DHA), 22 carbons and 6 double bonds.
Why Neutrox™ ?
PURE Hypochlorous Acid [ HOCl ]
Cl
O
H
Neutrox™
(NovaBay’s Proprietary Pure Hypochlorous Acid)
Excellent
activity
against a
broad range
of pathogens
Fast acting
onset of
activity
Effective
against
pathogens
commonly
found on the
lids & lashes
20
Avenova™ demonstrated excellent activity in solution
compared with the market leading lid and lash cleanser*
Organism S. aureus MRSA S. epidermidis S. haemolyticus P. acnes
NovaBay
Avenova®
< 1 minute < 1 minute < 1 minute < 1 minute < 1 minute
OcuSoft® Lid
Scrub Foam
> 30 minute > 30 minute > 30 minute > 30 minute > 30 minute
Avenova has higher Therapeutic
Index than Betadine
• Fast acting
onset of
microbial
activity
• Extremely
low toxicity
levels
• 1,000 times
less toxicity
than
Betadine®
21
Agent Tested Hypochlorous Acid
.01%
Betadine® Surgical
Scrub (Povidone-
iodine, 7.5%)
Nontoxic
Dilution
1:10 1:10,000
Time to 4 log10
kill
<1 minute >24 hours
Tested Against S. aureus ATCC 33591
*Antimicrobial Activity Comparison of Pure HypoChlorous Acid (0.01) with other Wound and Skin Cleansers at Non-Toxic
Concentrations, Russell Hoon, Suriani Abdul Rani, Ramin Najafi, Lu Wang, Dmitri Debabov; SAWC Spring 2013 and WHD
2013
Research on Biofilms
22
• Hypothesis is that
bacterial biofilm
plays a significant
role in delaying
wound healing
(Mertz – Wounds – May
2003)
A scanning electron micrograph of a porcine wound surface
with Staphylococcus aureus biofilm (6000X)
23
NovaBay Avenova® has Potent Anti-biofilm
Activity Compared to Saline
• In vitro Biofilm of P. fluorescens breaks up upon
introduction of Avenova®
SALINE (control) NovaBay Avenova
Hypochlorous Acid
Hypochlorous acid
(HOCL) released from
neutrophil cells
Part of body’s immune
response
Kills microorganisms
Neutralizes toxins
released from pathogens
and inflammatory
mediators
– helps suppress the body’s
inflammatory response
24
neutrophil
cell
HOCL
Representation of bacteria-produced
toxins which attack human cells
26
Representation of human cell response
to bacteria-produced toxins
27
Representation of the Mechanism of
Action of Hypochlorous .01% in In-Vitro
Models
Kills bacteria
Blocks
bacteria
produced
toxins
Blocks
human cell
produced
pro-
inflammatory
mediators
Dx of DES and Blepharitis:c/o irritation, pain; used Maxitrol drops and
ointment for 2 wks + warm compress and eye scrub with Baby Shampoo. Was
shown how to clean his lids and lashes in the office with Saline.
Still returned 2 wks later with similar symptoms. Maxitrol was d/c’d and
Avenova given. After 2 wks RTC with improved symptoms and improved
clinically on Exam.
After Use of Baby Shampoo After use of Avenova
Typical Blepharitis Case
Vision:
– OD 20/30
– OS 20/20-
TAP: OD 21 OS 23
Exam:
– Blepharitis
– Debris on lashes
– Conjunctival
hyperemia
• From end of 2008 until end of 2012
• Patient was seen 25 times
• Between visits he would call and get Rx for Ab.
• Received courses of:
• Bacitracin, neomycin, polymyxin, tobradex,
maxitrol, zylet, oral doxy, used Ocusoft.
• Patient developed skin ulcer from Ocusoft use
• 10% of patients who use these over the counter
eye lid scrubs will develop contact dermatitis
• Eczema type reaction due to their detergent
based components
Patient Case History: Chronic Blepharitis
32
Avenova™
(formerly i-Lid Cleanser)
33
with
Neutrox
as preservative
Avenova™
(formerly i-Lid Cleanser)
Severe Ocular Surface Disease
with Demodex
After 3 wks of use of Avenova™
Patients with acute or early stage meibomian gland
disease have a frothy tear film, or bubbles, which is
evident here at the lid margin.
Staph aureus is a consistent Lipase producer
Breaking down natural lipids (triglycerides) from
Meibomian Gland
Bacteria Lipase activity is responsible for the
breakdown of lipid to fatty acids
– [Invest. Ophthalmol. Vis. Sci.April 1986 vol. 27 no. 4 486-491]
Assuming Lipase causes saponification of lipid
and conversion to fatty acid and soap. Can
Avenova breakdown Lipase and prevent
saponification (soap making)
Lipase
Methyl Resorufin
Lipase Viability Assay
Lipase Substrate
Method used:
1) We treated Lipase with the test article
2) We looked for Lipase viability next
Avenova™(formerly i-Lid Cleanser)
inactivates Bacterial Lipase
Chronic use of antibiotic
will result in antibiotic
resistant strains
Product Comparison (Ingredients)
50
OCuSoft SteriLid Oasis
Lid
and
Lash
LIDCLE
NZ
VisiClean
se
Eye
Scrub
Ingredient
s
Hypochlorous
acid, saline
Water , PEG-
80 Sorbitan
Laurate ,
Sodium
Tricedeth
Sulfate ,
PEG-150
Distearate ,
Disodium
Lauroamphod
iacetate ,
Cocamidopro
pyl
Hydroxysultai
ne , Sodium
Laureth-13
Carboxylate ,
Sodium
Chloride ,
Quaternium-
15
Water , PEG 80
, Sorbitan
Laurate ,
Sodium
Trideceth
Sulfate ,
Cocamidopropyl
Betaine ,
Sodium
Lauroamphoace
tate , PEG 150
Distearate ,
Sodium Laureth
13 Carboxylate ,
Linalool Oil ,
Hepes Acetate ,
Sodium
Perborate
Monohydrate ,
Panthenol ,
Allantoin
(Comfrey Root)
, Sodium
Chloride , Tea
Tree (Melaleuca
Alternifolia) Oil ,
Water,
Poloxamer,
Polyethylen
e,Glycol,Bo
rate,Hyalur
onan,Methy
lparaben,
Carbopol
940
non-foaming
pH balanced
formulation of
non-ionic
surfactant in
purified water
Water,
Cocamidopropyl
Betaine, PEG-
80 Sorbitan,
Laurate,
Sodium
Trideceth
Sulfate, PEG-
150 Distearate,
Aloe,
Barbadensis
Leaf Extract,
Chamomilla
Recutita
(Matricaria)
Flower, Extract,
Cucumis
Sativus
(Cucumber)
Fruit Extract,
Althaea
Officinalis, Root
Extract, Avena
Sativa (Oat)
Kernel Extract,
Tetrasodium
Water USP
(Purified),
PEG 200
Hydrogenated
Glyceryl
Palmate,
Disodium
Laureth
Sulfosuccinat
e,
Cocoamidopr
opylamine
Oxide, PEG
80 Glyceryl
Cocoate,
Benzyl
Alcohol,
Edetate
Disodium
To Open an account contact:
NovaBay by calling:
1-800-890-0329
Retail to patients: $30
If used according to instructions:
1st bottle will last 2 weeks
(2X per day application)
2nd bottle will last 1 month
(1X per day application)
Thank you!

More Related Content

Similar to Avenova January 2015 Final

The old army do you apply it right
The old army do you apply it rightThe old army do you apply it right
The old army do you apply it rightwan zuraini
 
Alcrea+SourceOne Present VESIsorb ExpoWest2013
Alcrea+SourceOne Present VESIsorb ExpoWest2013Alcrea+SourceOne Present VESIsorb ExpoWest2013
Alcrea+SourceOne Present VESIsorb ExpoWest2013Alcrea
 
Fibrocell Science, Inc. (OTCBB: FCSC)- UBS Investor Conference, September 2011
Fibrocell Science, Inc. (OTCBB: FCSC)- UBS Investor Conference, September 2011Fibrocell Science, Inc. (OTCBB: FCSC)- UBS Investor Conference, September 2011
Fibrocell Science, Inc. (OTCBB: FCSC)- UBS Investor Conference, September 2011ProActive Capital Resources Group
 
Nanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery systemNanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery systemDeeptiMSati
 
Chronic Wound Management Strategy
Chronic Wound Management StrategyChronic Wound Management Strategy
Chronic Wound Management Strategywan zuraini
 
Steve Berger - Manufacturing & Development Update
Steve Berger - Manufacturing & Development UpdateSteve Berger - Manufacturing & Development Update
Steve Berger - Manufacturing & Development UpdateJohn Blue
 
The Old Army vs New Army
The Old Army vs New ArmyThe Old Army vs New Army
The Old Army vs New Armywan zuraini
 
Katy Najafi and Steve Lichtenstein Ophthalmology Time
Katy Najafi and Steve Lichtenstein Ophthalmology TimeKaty Najafi and Steve Lichtenstein Ophthalmology Time
Katy Najafi and Steve Lichtenstein Ophthalmology TimeJeff Gilbert
 
Katy Najafi and Steve Lichtenstein Ophthalmology Time
Katy Najafi and Steve Lichtenstein Ophthalmology TimeKaty Najafi and Steve Lichtenstein Ophthalmology Time
Katy Najafi and Steve Lichtenstein Ophthalmology TimeMary Mac Lax, M.S., CCC-SLP
 
Upstream Viral Safety – Protect your bioreactor with Virus Filtration
Upstream Viral Safety – Protect your bioreactor with Virus FiltrationUpstream Viral Safety – Protect your bioreactor with Virus Filtration
Upstream Viral Safety – Protect your bioreactor with Virus FiltrationMilliporeSigma
 
Liposomes & Niosomes.pptx
Liposomes & Niosomes.pptxLiposomes & Niosomes.pptx
Liposomes & Niosomes.pptxSasidharRlc2
 
Nanosynergy WorldWide - 2014
Nanosynergy WorldWide - 2014Nanosynergy WorldWide - 2014
Nanosynergy WorldWide - 2014kaoscol
 
Vaginal drug delivery
Vaginal drug deliveryVaginal drug delivery
Vaginal drug deliveryNithin Kurian
 
Surgical skin antiseptics
Surgical skin antisepticsSurgical skin antiseptics
Surgical skin antisepticsWafiMohammed
 
Biovex Sanitizer
Biovex SanitizerBiovex Sanitizer
Biovex SanitizerJonGot
 
Biosimilars IN RETINAL DISORDERS -DR AJAY DUDANI
Biosimilars  IN RETINAL DISORDERS -DR AJAY DUDANIBiosimilars  IN RETINAL DISORDERS -DR AJAY DUDANI
Biosimilars IN RETINAL DISORDERS -DR AJAY DUDANIAjayDudani1
 
Biosimilars ANTIVEGF IN RETINA
Biosimilars   ANTIVEGF IN RETINABiosimilars   ANTIVEGF IN RETINA
Biosimilars ANTIVEGF IN RETINAAjayDudani1
 

Similar to Avenova January 2015 Final (20)

The old army do you apply it right
The old army do you apply it rightThe old army do you apply it right
The old army do you apply it right
 
Alcrea+SourceOne Present VESIsorb ExpoWest2013
Alcrea+SourceOne Present VESIsorb ExpoWest2013Alcrea+SourceOne Present VESIsorb ExpoWest2013
Alcrea+SourceOne Present VESIsorb ExpoWest2013
 
Fibrocell Science, Inc. (OTCBB: FCSC)- UBS Investor Conference, September 2011
Fibrocell Science, Inc. (OTCBB: FCSC)- UBS Investor Conference, September 2011Fibrocell Science, Inc. (OTCBB: FCSC)- UBS Investor Conference, September 2011
Fibrocell Science, Inc. (OTCBB: FCSC)- UBS Investor Conference, September 2011
 
Nanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery systemNanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery system
 
Ppt 2011
Ppt 2011Ppt 2011
Ppt 2011
 
Chronic Wound Management Strategy
Chronic Wound Management StrategyChronic Wound Management Strategy
Chronic Wound Management Strategy
 
Steve Berger - Manufacturing & Development Update
Steve Berger - Manufacturing & Development UpdateSteve Berger - Manufacturing & Development Update
Steve Berger - Manufacturing & Development Update
 
The Old Army vs New Army
The Old Army vs New ArmyThe Old Army vs New Army
The Old Army vs New Army
 
Katy Najafi and Steve Lichtenstein Ophthalmology Time
Katy Najafi and Steve Lichtenstein Ophthalmology TimeKaty Najafi and Steve Lichtenstein Ophthalmology Time
Katy Najafi and Steve Lichtenstein Ophthalmology Time
 
Katy Najafi and Steve Lichtenstein Ophthalmology Time
Katy Najafi and Steve Lichtenstein Ophthalmology TimeKaty Najafi and Steve Lichtenstein Ophthalmology Time
Katy Najafi and Steve Lichtenstein Ophthalmology Time
 
Upstream Viral Safety – Protect your bioreactor with Virus Filtration
Upstream Viral Safety – Protect your bioreactor with Virus FiltrationUpstream Viral Safety – Protect your bioreactor with Virus Filtration
Upstream Viral Safety – Protect your bioreactor with Virus Filtration
 
Liposomes & Niosomes.pptx
Liposomes & Niosomes.pptxLiposomes & Niosomes.pptx
Liposomes & Niosomes.pptx
 
Nanosynergy WorldWide - 2014
Nanosynergy WorldWide - 2014Nanosynergy WorldWide - 2014
Nanosynergy WorldWide - 2014
 
Advil vs nano
Advil vs nanoAdvil vs nano
Advil vs nano
 
Vaginal drug delivery
Vaginal drug deliveryVaginal drug delivery
Vaginal drug delivery
 
Surgical skin antiseptics
Surgical skin antisepticsSurgical skin antiseptics
Surgical skin antiseptics
 
Biovex Sanitizer
Biovex SanitizerBiovex Sanitizer
Biovex Sanitizer
 
Biosimilars IN RETINAL DISORDERS -DR AJAY DUDANI
Biosimilars  IN RETINAL DISORDERS -DR AJAY DUDANIBiosimilars  IN RETINAL DISORDERS -DR AJAY DUDANI
Biosimilars IN RETINAL DISORDERS -DR AJAY DUDANI
 
Biosimilars ANTIVEGF IN RETINA
Biosimilars   ANTIVEGF IN RETINABiosimilars   ANTIVEGF IN RETINA
Biosimilars ANTIVEGF IN RETINA
 
Phage therapy
Phage therapyPhage therapy
Phage therapy
 

Avenova January 2015 Final

  • 1. Avenova (formerly i-Lid™ Cleanser) A NEW DIMENSION IN LID AND LASH HYGIENE Ron Najafi, Ph.D. Chairman & CEO NovaBay Pharmaceuticals, Inc. email: Rnajafi@NovaBay.com (New York Stock Exchange: NBY)
  • 2. The San Francisco Bay Area Home to NovaBay Pharmaceuticals (A view from our facilities)
  • 3. NovaBay Pharmaceuticals Employees: 28, founded in 2000 by Ron Najafi, Ph.D. (chemist) NovaBay Dedicated Sales Force: 39, all across the US Location: Emeryville, CA Capital Structure: Public Company, listed on NYSE: NBY Focus: Non-Antibiotic Antimicrobials Marketed products (Neutrox platform) – Avenova: (formerly i-Lid™ Cleanser ) . Lid & Lash Hygiene, Blepharitis, MGD and Dry Eye. – NeutroPhase: Diabetic Ulcer, Venous and Pressure Ulcers, including NF) – CelleRx: Burn associated with Post Laser Resurfacing Pre-Market Products (Aganocide platform) – Bladder Irrigation Solution for patients with Spinal Cord Injury and recurrent blockage and encrustation – Skin Infection (Impetigo and Acne) Global Partnerships: PBE (in the US), IHT (USA), Galderma (France), Virbac (France), Pioneer Pharma (China and Southeast Asia), Shin Poong (Korea), Biopharm (North African and Middle East)
  • 4. “The Most Under- recognized The Most Underappreciated The Most Undertreated disease in Ophthalmic Care”
  • 5. Anatomy of Eye and Lid and Meibomian Gland
  • 7. Blepharitis Causes: Meibomian Gland Dysfunction (MGD). Gland Oil Keep the water from evaporating & preventing Dry Eye.
  • 8. Expressing the Meibomian Gland Shows Dysfunction present Tooth Paste like consistency is bad Doctor is pressing against lower eye lid
  • 9. Blepharitis / Meibomian Gland Dysfunction/ Associated Dry Eye / Pre-Operative Lid Hygiene Chronic lid & lash hygiene  - 24 million blepharitis patients  - 6.5 million MGD dry eye patients  - 3 million cataract patients  - 1.5 million refractive surgery patients
  • 10. Avenova (formerly i-Lid™ Cleanser) for Conditions of the Lids and Lashes Proprietary Technology – Neutrox : NovaBay Proprietary Pure 0.01% Pure hypochlorous solution in saline – No bleach impurities, which is present in Dakin and Dakin-like solutions – No resistance expected based on novel mechanism of action Significant Market / Poorly Served – Eyelid hygiene therapy, part of the treatment for blepharitis – Currently marketed products have little to no benefit – 4% of 18 – 22 year olds – 71% of 65+ year olds
  • 11. Why Control of Lid Flora Matters? Blepharitis MGD with secondary staph overpopulation Pre-op surgical prophylaxis – Refractive – Cataract – Retinal Contact lens wear
  • 14.
  • 15.
  • 16. Omega 3 Fatty Acid Omega 3 Fatty Acid, Rich in EPA & DHA Eicosapentaenoic Acid (EPA), 20 carbons and 5 double bonds. Docosahexaenoic Acid (DHA), 22 carbons and 6 double bonds.
  • 17. Why Neutrox™ ? PURE Hypochlorous Acid [ HOCl ] Cl O H
  • 18. Neutrox™ (NovaBay’s Proprietary Pure Hypochlorous Acid) Excellent activity against a broad range of pathogens Fast acting onset of activity Effective against pathogens commonly found on the lids & lashes
  • 19. 20 Avenova™ demonstrated excellent activity in solution compared with the market leading lid and lash cleanser* Organism S. aureus MRSA S. epidermidis S. haemolyticus P. acnes NovaBay Avenova® < 1 minute < 1 minute < 1 minute < 1 minute < 1 minute OcuSoft® Lid Scrub Foam > 30 minute > 30 minute > 30 minute > 30 minute > 30 minute
  • 20. Avenova has higher Therapeutic Index than Betadine • Fast acting onset of microbial activity • Extremely low toxicity levels • 1,000 times less toxicity than Betadine® 21 Agent Tested Hypochlorous Acid .01% Betadine® Surgical Scrub (Povidone- iodine, 7.5%) Nontoxic Dilution 1:10 1:10,000 Time to 4 log10 kill <1 minute >24 hours Tested Against S. aureus ATCC 33591 *Antimicrobial Activity Comparison of Pure HypoChlorous Acid (0.01) with other Wound and Skin Cleansers at Non-Toxic Concentrations, Russell Hoon, Suriani Abdul Rani, Ramin Najafi, Lu Wang, Dmitri Debabov; SAWC Spring 2013 and WHD 2013
  • 21. Research on Biofilms 22 • Hypothesis is that bacterial biofilm plays a significant role in delaying wound healing (Mertz – Wounds – May 2003) A scanning electron micrograph of a porcine wound surface with Staphylococcus aureus biofilm (6000X)
  • 22. 23 NovaBay Avenova® has Potent Anti-biofilm Activity Compared to Saline • In vitro Biofilm of P. fluorescens breaks up upon introduction of Avenova® SALINE (control) NovaBay Avenova
  • 23. Hypochlorous Acid Hypochlorous acid (HOCL) released from neutrophil cells Part of body’s immune response Kills microorganisms Neutralizes toxins released from pathogens and inflammatory mediators – helps suppress the body’s inflammatory response 24 neutrophil cell HOCL
  • 24.
  • 25. Representation of bacteria-produced toxins which attack human cells 26
  • 26. Representation of human cell response to bacteria-produced toxins 27
  • 27. Representation of the Mechanism of Action of Hypochlorous .01% in In-Vitro Models Kills bacteria Blocks bacteria produced toxins Blocks human cell produced pro- inflammatory mediators
  • 28. Dx of DES and Blepharitis:c/o irritation, pain; used Maxitrol drops and ointment for 2 wks + warm compress and eye scrub with Baby Shampoo. Was shown how to clean his lids and lashes in the office with Saline. Still returned 2 wks later with similar symptoms. Maxitrol was d/c’d and Avenova given. After 2 wks RTC with improved symptoms and improved clinically on Exam. After Use of Baby Shampoo After use of Avenova
  • 29. Typical Blepharitis Case Vision: – OD 20/30 – OS 20/20- TAP: OD 21 OS 23 Exam: – Blepharitis – Debris on lashes – Conjunctival hyperemia
  • 30. • From end of 2008 until end of 2012 • Patient was seen 25 times • Between visits he would call and get Rx for Ab. • Received courses of: • Bacitracin, neomycin, polymyxin, tobradex, maxitrol, zylet, oral doxy, used Ocusoft. • Patient developed skin ulcer from Ocusoft use • 10% of patients who use these over the counter eye lid scrubs will develop contact dermatitis • Eczema type reaction due to their detergent based components Patient Case History: Chronic Blepharitis
  • 33. Severe Ocular Surface Disease with Demodex
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39. After 3 wks of use of Avenova™
  • 40.
  • 41.
  • 42. Patients with acute or early stage meibomian gland disease have a frothy tear film, or bubbles, which is evident here at the lid margin.
  • 43.
  • 44.
  • 45. Staph aureus is a consistent Lipase producer Breaking down natural lipids (triglycerides) from Meibomian Gland Bacteria Lipase activity is responsible for the breakdown of lipid to fatty acids – [Invest. Ophthalmol. Vis. Sci.April 1986 vol. 27 no. 4 486-491] Assuming Lipase causes saponification of lipid and conversion to fatty acid and soap. Can Avenova breakdown Lipase and prevent saponification (soap making)
  • 46. Lipase Methyl Resorufin Lipase Viability Assay Lipase Substrate Method used: 1) We treated Lipase with the test article 2) We looked for Lipase viability next
  • 48. Chronic use of antibiotic will result in antibiotic resistant strains
  • 49. Product Comparison (Ingredients) 50 OCuSoft SteriLid Oasis Lid and Lash LIDCLE NZ VisiClean se Eye Scrub Ingredient s Hypochlorous acid, saline Water , PEG- 80 Sorbitan Laurate , Sodium Tricedeth Sulfate , PEG-150 Distearate , Disodium Lauroamphod iacetate , Cocamidopro pyl Hydroxysultai ne , Sodium Laureth-13 Carboxylate , Sodium Chloride , Quaternium- 15 Water , PEG 80 , Sorbitan Laurate , Sodium Trideceth Sulfate , Cocamidopropyl Betaine , Sodium Lauroamphoace tate , PEG 150 Distearate , Sodium Laureth 13 Carboxylate , Linalool Oil , Hepes Acetate , Sodium Perborate Monohydrate , Panthenol , Allantoin (Comfrey Root) , Sodium Chloride , Tea Tree (Melaleuca Alternifolia) Oil , Water, Poloxamer, Polyethylen e,Glycol,Bo rate,Hyalur onan,Methy lparaben, Carbopol 940 non-foaming pH balanced formulation of non-ionic surfactant in purified water Water, Cocamidopropyl Betaine, PEG- 80 Sorbitan, Laurate, Sodium Trideceth Sulfate, PEG- 150 Distearate, Aloe, Barbadensis Leaf Extract, Chamomilla Recutita (Matricaria) Flower, Extract, Cucumis Sativus (Cucumber) Fruit Extract, Althaea Officinalis, Root Extract, Avena Sativa (Oat) Kernel Extract, Tetrasodium Water USP (Purified), PEG 200 Hydrogenated Glyceryl Palmate, Disodium Laureth Sulfosuccinat e, Cocoamidopr opylamine Oxide, PEG 80 Glyceryl Cocoate, Benzyl Alcohol, Edetate Disodium
  • 50. To Open an account contact: NovaBay by calling: 1-800-890-0329 Retail to patients: $30 If used according to instructions: 1st bottle will last 2 weeks (2X per day application) 2nd bottle will last 1 month (1X per day application)